Shen Haiyuan, Zhou Shu, Lou Yun, Gao Yangjuan, Cao Shouji, Wu Du, Li Guoqiang
1 Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
2 Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818785980. doi: 10.1177/1533033818785980.
We evaluated microwave-assisted liver resection for hepatocellular carcinoma.
We enrolled 79 patients in this study, and microwave ablation was used for liver resection. Patients were randomized to group A (50.6%; n = 40), liver resection without microwave ablation, or group B (49.4%; n = 39), liver resection performed using microwave ablation. Data were analyzed for statistical significance.
Of the participants enrolled, 60 were male, and the participant's average age was 59.32 ± 10.34 years. The mean overall tumor diameter was 4.39 (2.00) cm, and this did not differ between groups. Intraoperative blood loss in group B was significantly less than that in group A ( P < .001). No differences were reported between the 2 groups regarding surgical time ( P = .914), postoperative morbidity ( P = .718), and late postoperative complications ( P = .409). Postoperative drainage volume for group B was less than that of group A on the first ( P = .005) and third ( P = .019) day after surgery. The time of postoperative hospitalization in group B was significantly shorter than that in group A ( P < .001). Local recurrence was noted in 18.99% of cases (n = 15) in group B, which is less than that of group A ( P = 0.047), while in group B distant metastasis is less but not statistically significant ( P = 0.061). The 1-year and 3-year cumulative survival rates were 57% and 93.7%, respectively.
The curative effects of liver resection combined with microwave ablation during operation are superior to only liver resection in the treatment of primary liver cancer.
我们评估了微波辅助肝切除术治疗肝细胞癌的效果。
本研究纳入79例患者,采用微波消融辅助肝切除术。患者被随机分为A组(50.6%;n = 40),即未进行微波消融的肝切除术组,或B组(49.4%;n = 39),即采用微波消融进行肝切除术的组。对数据进行统计学显著性分析。
纳入的参与者中,60例为男性,参与者的平均年龄为59.32±10.34岁。肿瘤平均总直径为4.39(2.00)cm,两组之间无差异。B组术中出血量显著少于A组(P <.001)。两组在手术时间(P =.914)、术后发病率(P =.718)和术后晚期并发症(P =.409)方面无差异。B组术后第一天(P =.005)和第三天(P =.019)的引流量少于A组。B组术后住院时间显著短于A组(P <.001)。B组局部复发率为18.99%(n = 15),低于A组(P = 0.047),而B组远处转移较少但无统计学显著性(P = 0.061)。1年和3年累积生存率分别为57%和93.7%。
手术中肝切除联合微波消融治疗原发性肝癌的疗效优于单纯肝切除。